CLINICAL_TRIALS
research
· 2018-07-26
Clinical Trial Update: Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
Summary
The update summarizes early participants' perspectives on informed consent for whole-genome sequencing in an NHGRI-supported study and the ideals and norms they…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Coronary Artery Disease, Proteus Syndrome | Status: COMPLETED